Literature DB >> 18455243

Regulatory T cells in paraneoplastic neurological syndromes.

Takashi Tani1, Keiko Tanaka, Jiro Idezuka, Masatoyo Nishizawa.   

Abstract

Focusing on CD4(+)CD25(+) regulatory T lymphocytes (T(reg)), we studied the gene expression of T(reg) functional molecules in peripheral blood lymphocytes of patients with paraneoplastic neurological syndrome (PNS), including Lambert-Eaton myasthenic syndrome (LEMS) with small cell lung carcinoma (SCLC) and anti-Hu- or anti-Yo-antibody-positive PNS. T(reg)-rich subsets were sorted from the patients' peripheral blood mononuclear cells, and the mRNA expression levels of their functional genes were measured. The expression levels of FOXP3, TGF-beta and CTLA4 mRNA in T(reg)-rich subsets of PNS patients were down-regulated compared with that of SCLC patients without PNS. These results suggest that T(reg) dysfunction plays a role in PNS development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455243     DOI: 10.1016/j.jneuroim.2008.03.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

Review 1.  The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.

Authors:  Leora Horn; Martin Reck; David R Spigel
Journal:  Oncologist       Date:  2016-06-27

Review 2.  Voltage gated calcium channel antibody-related neurological diseases.

Authors:  Can Ebru Bekircan-Kurt; Eda Derle Çiftçi; Aslı Tuncer Kurne; Banu Anlar
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 3.  Immune checkpoint inhibitors in small cell lung cancer.

Authors:  Suchita Pakkala; Taofeek K Owonikoko
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 4.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

5.  Large granular lymphocytic leukemia associated with Lambert-Eaton Myasthenic Syndrome: A case report.

Authors:  Richard Lemal; Carine Chaleteix; Patrice Minard; Corinne Roche; Jacques-Olivier Bay; Olivier Tournilhac; Thierry Lamy
Journal:  Leuk Res Rep       Date:  2013-04-02

6.  Paraneoplastic Sensory Polyneuropathy Related to Anti-PD-L1-including Anticancer Treatment in a Patient with Lung Cancer.

Authors:  Toshiki Morimoto; Takeshi Orihashi; Kei Yamasaki; Masahiro Tahara; Kaori Kato; Kazuhiro Yatera
Journal:  Intern Med       Date:  2020-12-15       Impact factor: 1.271

7.  CDR2 antigen and Yo antibodies.

Authors:  Cecilie Totland; Nina K Aarskog; Tilo W Eichler; Mette Haugen; Jane K Nøstbakken; Sissel E Monstad; Helga B Salvesen; Sverre Mørk; Bjørn I Haukanes; Christian A Vedeler
Journal:  Cancer Immunol Immunother       Date:  2010-11-16       Impact factor: 6.968

8.  Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy.

Authors:  Nils Erik Gilhus
Journal:  Autoimmune Dis       Date:  2011-09-29

Review 9.  Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.

Authors:  Meleeneh Kazarian; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2011-03-30       Impact factor: 27.401

Review 10.  Immunology primer for neurosurgeons and neurologists part 2: Innate brain immunity.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2013-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.